These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 20500770

  • 1. Deposition of chromatin-IgG complexes in skin of nephritic MRL-lpr/lpr mice is associated with increased local matrix metalloprotease activities.
    Hedberg A, Fismen S, Fenton KA, Mortensen ES, Rekvig OP.
    Exp Dermatol; 2010 Aug; 19(8):e265-74. PubMed ID: 20500770
    [Abstract] [Full Text] [Related]

  • 2. Circulating chromatin-anti-chromatin antibody complexes bind with high affinity to dermo-epidermal structures in murine and human lupus nephritis.
    Fismen S, Hedberg A, Fenton KA, Jacobsen S, Krarup E, Kamper AL, Rekvig OP, Mortensen ES.
    Lupus; 2009 Jun; 18(7):597-607. PubMed ID: 19433459
    [Abstract] [Full Text] [Related]

  • 3. Pure anti-dsDNA mAbs need chromatin structures to promote glomerular mesangial deposits in BALB/c mice.
    Fenton KA, Tømmerås B, Marion TN, Rekvig OP.
    Autoimmunity; 2010 Mar; 43(2):179-88. PubMed ID: 19835488
    [Abstract] [Full Text] [Related]

  • 4. Anti-dsDNA antibodies promote initiation, and acquired loss of renal Dnase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice.
    Fenton K, Fismen S, Hedberg A, Seredkina N, Fenton C, Mortensen ES, Rekvig OP.
    PLoS One; 2009 Dec 29; 4(12):e8474. PubMed ID: 20041189
    [Abstract] [Full Text] [Related]

  • 5. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K, Watanabe N, Akikusa B, Kurasawa K, Matsumura R, Saito Y, Iwamoto I, Saito T.
    Arthritis Rheum; 2003 Feb 29; 48(2):486-94. PubMed ID: 12571859
    [Abstract] [Full Text] [Related]

  • 6. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.
    J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217
    [Abstract] [Full Text] [Related]

  • 7. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A.
    J Rheumatol; 2010 Jan 01; 37(1):60-70. PubMed ID: 19955044
    [Abstract] [Full Text] [Related]

  • 8. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 9. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis.
    Rops AL, van den Hoven MJ, Bakker MA, Lensen JF, Wijnhoven TJ, van den Heuvel LP, van Kuppevelt TH, van der Vlag J, Berden JH.
    Nephrol Dial Transplant; 2007 Jul 15; 22(7):1891-902. PubMed ID: 17550924
    [Abstract] [Full Text] [Related]

  • 10. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B.
    J Am Soc Nephrol; 2005 Dec 15; 16(12):3592-601. PubMed ID: 16267157
    [Abstract] [Full Text] [Related]

  • 11. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
    Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez de Lema G, Strutz F, Bauer S, Rutz M, Wagner H, Gröne HJ, Schlöndorff D.
    FASEB J; 2004 Mar 15; 18(3):534-6. PubMed ID: 14734643
    [Abstract] [Full Text] [Related]

  • 12. Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice.
    Lu Q, Shen N, Li XM, Chen SL.
    Genes Immun; 2007 Oct 15; 8(7):590-603. PubMed ID: 17728792
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS, Gröne HJ, Segerer S, Ciubar R, Belemezova E, Henger A, Kretzler M, Schlöndorff D, Anders HJ.
    J Am Soc Nephrol; 2005 May 15; 16(5):1326-38. PubMed ID: 15772251
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes.
    Mortensen ES, Rekvig OP.
    J Am Soc Nephrol; 2009 Apr 15; 20(4):696-704. PubMed ID: 19329762
    [Abstract] [Full Text] [Related]

  • 18. Abrogation of skin disease in LUPUS-prone MRL/FASlpr mice by means of a novel tylophorine analog.
    Choi JY, Gao W, Odegard J, Shiah HS, Kashgarian M, McNiff JM, Baker DC, Cheng YC, Craft J.
    Arthritis Rheum; 2006 Oct 15; 54(10):3277-83. PubMed ID: 17009262
    [Abstract] [Full Text] [Related]

  • 19. Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration.
    Licht R, van Bruggen MC, Oppers-Walgreen B, Rijke TP, Berden JH.
    Arthritis Rheum; 2001 Jun 15; 44(6):1320-30. PubMed ID: 11407691
    [Abstract] [Full Text] [Related]

  • 20. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis.
    Takahashi S, Nose M, Sasaki J, Yamamoto T, Kyogoku M.
    J Immunol; 1991 Jul 15; 147(2):515-9. PubMed ID: 2071894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.